112
Views
1
CrossRef citations to date
0
Altmetric
Research Reports

Rates of diagnostic genetic testing in a tertiary ocular genetics clinic

, ORCID Icon, &
Pages 271-274 | Received 01 Oct 2019, Accepted 12 Apr 2020, Published online: 27 Apr 2020

References

  • Gillespie RL, Hall G, Black GC. Genetic testing for inherited ocular disease: delivering on the promise at last? Clin Experiment Ophthalmol. 2014;42:65–77. doi:10.1111/ceo.12159. Cited in PubMed; PMID: 23845030.
  • Day MA, Sutherland JE. Genetic counseling and genetic testing in ophthalmology. Curr Opin Ophthalmol. 2009;20(5):343–50. doi:10.1097/ICU.0b013e32832f7f0d. Cited in PubMed; PMID: 19620864.
  • Maguire AM, Russell S, Wellman JA, Chung DC, Yu ZF, Tillman A, Wittes J, Pappas J, Elci O, Marshall KA, et al. Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: results of phase 1 and 3 trials. Ophthalmology. 2019 Sep;126(9):1273–85. doi:10.1016/j.ophtha.2019.06.017. Cited in PubMed; PMID: 31443789.
  • Koenekoop RK, Lopez I, den Hollander AI, Allikmets R, Cremers FP. Genetic testing for retinal dystrophies and dysfunctions: benefits, dilemmas and solutions. Clin Exp Ophthalmol. 2007 Jul;35(5):473–85. doi:10.1111/j.1442-9071.2007.01534.x. Cited in PubMed; PMID: 17651254.
  • Moore NA, Morral N, Ciulla TA, Bracha P. Gene therapy for inherited retinal and optic nerve degenerations. Expert Opin Biol Ther. 2018 Jan;18(1):37–49. doi:10.1080/14712598.2018.1389886.
  • Al-Zaidy SA, Kolb SJ, Lowes L, Alfano LN, Shell R, Church KR, Nagendran S, Sproule DM, Feltner DE, Wells C, et al. AVXS-101 (Onasemnogene Abeparvovec) for SMA1: comparative study with a prospective natural history cohort. J Neuromuscul Dis. 2019;6(3):307–17. doi:10.3233/JND-190403. Cited in PubMed; PMID: 31381526.
  • Capasso JE. The cost of genetic testing for ocular disease: who pays? Curr Opin Ophthalmol. 2014 Sep;25(5):394–99. doi:10.1097/ICU.0000000000000085. Cited in PubMed; PMID: 25010001.
  • Morad Y, Sutherland J, DaSilva L, Ulster A, Shik J, Gallie B, Héon E, Levin AV. Ocular genetics program: multidisciplinary care of patients with ocular genetic eye disease. Can J Ophthalmol. 2007 Oct;42(5):734–38. doi:10.1139/i07-144. Cited in PubMed; PMID: 17891201.
  • Zanolli MT, Khetan V, Dotan G, Pizzi L, Levin AV. Should patients with ocular genetic disorders have genetic testing? Curr Opin Ophthalmol. 2014 Sep;25(5):359–65. doi:10.1097/ICU.0000000000000083. Cited in PubMed; PMID: 24991870.
  • Mezer E, Wygnanski-Jaffe T. Ethical issues in ocular genetics. Curr Opin Ophthalmol. 2009 Sep;20(5):382–86. doi:10.1097/ICU.0b013e32832f7feb. Cited in PubMed; PMID: 19587598.
  • Hayden S, Mange S, Duquette D, Petrucelli N, Raymond VM. BRCA clinical network partners. Large, prospective analysis of the reasons patients do not pursue BRCA genetic testing following genetic counseling. J Genet Couns. 2017 Aug;26(4):859–65. doi:10.1007/s10897-016-0064-5. Cited in PubMed; PMID: 28093663.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.